Chemical Compound Review:
Xalatan propan-2-yl (E)-7-[(1R,2R,3R,5S)-3,5...
Synonyms:
latanaprost, PhXA34, PhXA41, PhXA 41, AC1NQZZ7, ...
Mietz,
Esser,
Welsandt,
Kociok,
Hueber,
Joussen,
Esser,
Krieglstein,
Miyake,
Ota,
Maekubo,
Ichihashi,
Miyake,
Quaranta,
Gandolfo,
Turano,
Rovida,
Pizzolante,
Musig,
Gandolfo,
Hinz,
Rösch,
Ramer,
Tamm,
Brune,
Diestelhorst,
Nordmann,
Toris,
Kurtz,
Shemesh,
Varma,
Winarko,
Kiat-Winarko,
Winarko,
Kondo,
Sawada,
Yamamoto,
Taniguchi,
Weinreb,
Lindsey,
Marchenko,
Marchenko,
Angert,
Strongin,
Stjernschantz,
Selén,
Astin,
Resul,
Rask-Andersen,
Friberg,
Johansson,
Stjernschantz,
Franks,
Renard,
Cunliffe,
Rojanapongpun,
Gutiérrez-Ortiz,
Teus,
Bolivar,
- Characterization of a rabbit kidney prostaglandin F(2{alpha}) receptor exhibiting G(i)-restricted signaling that inhibits water absorption in the collecting duct. Hébert, R.L., Carmosino, M., Saito, O., Yang, G., Jackson, C.A., Qi, Z., Breyer, R.M., Natarajan, C., Hata, A.N., Zhang, Y., Guan, Y., Breyer, M.D. J. Biol. Chem. (2005)
- Concentration of latanoprost ophthalmic solution after 4 to 6 weeks' use in an eye clinic setting. Varma, R., Winarko, J., Kiat-Winarko, T., Winarko, B. Invest. Ophthalmol. Vis. Sci. (2006)
- Short-term effects of latanoprost on anterior chamber depth in patients with glaucoma or ocular hypertension. Guti??rrez-Ortiz, C., Teus, M.A., Bolivar, G. Invest. Ophthalmol. Vis. Sci. (2006)
- Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study. Pisella, P.J., Debbasch, C., Hamard, P., Creuzot-Garcher, C., Rat, P., Brignole, F., Baudouin, C. Invest. Ophthalmol. Vis. Sci. (2004)
- Effect of hyaluronic acid on intraocular pressure in rats. Benozzi, J., Nahum, L.P., Campanelli, J.L., Rosenstein, R.E. Invest. Ophthalmol. Vis. Sci. (2002)
- Melanin in the trabecular meshwork is associated with age, POAG but not Latanoprost treatment. A masked morphometric study. Cracknell, K.P., Grierson, I., Hogg, P., Majekodunmi, A.A., Watson, P., Marmion, V. Exp. Eye Res. (2006)
- The efficacy and safety of once-daily versus once-weekly latanoprost treatment for increased intraocular pressure. Kurtz, S., Shemesh, G. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics. (2004)
- Correlation between individual differences in intraocular pressure reduction and outflow facility due to latanoprost in normal-tension glaucoma patients. Kondo, N., Sawada, A., Yamamoto, T., Taniguchi, T. Jpn. J. Ophthalmol. (2006)
- Effects of intratympanic injection of latanoprost in Meniere's disease: a randomized, placebo-controlled, double-blind, pilot study. Rask-Andersen, H., Friberg, U., Johansson, M., Stjernschantz, J. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. (2005)
- Microvascular effects of selective prostaglandin analogues in the eye with special reference to latanoprost and glaucoma treatment. Stjernschantz, J., Selén, G., Astin, M., Resul, B. Progress in retinal and eye research. (2000)
- Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost. Oh, D.J., Martin, J.L., Williams, A.J., Peck, R.E., Pokorny, C., Russell, P., Birk, D.E., Rhee, D.J. Invest. Ophthalmol. Vis. Sci. (2006)
- Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost. Gandolfi, S.A., Cimino, L. Ophthalmology (2003)
- A double-masked, randomized clinical trial comparing latanoprost with unoprostone in patients with open-angle glaucoma or ocular hypertension. Susanna, R., Giampani, J., Borges, A.S., Vessani, R.M., Jordao, M.L. Ophthalmology (2001)
- A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension. Franks, W.A., Renard, J.P., Cunliffe, I.A., Rojanapongpun, P. Clinical therapeutics. (2006)
- Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias. Miyake, K., Ota, I., Maekubo, K., Ichihashi, S., Miyake, S. Arch. Ophthalmol. (1999)
- Combined therapy of pilocarpine or latanoprost with timolol versus latanoprost monotherapy. Diestelhorst, M., Nordmann, J.P., Toris, C.B. Survey of ophthalmology. (2002)
- Reduction of intraocular pressure in mouse eyes treated with latanoprost. Aihara, M., Lindsey, J.D., Weinreb, R.N. Invest. Ophthalmol. Vis. Sci. (2002)
- Effect of latanoprost and timolol on the histopathology of the rabbit conjunctiva. Mietz, H., Schlötzer-Schrehardt, U., Strassfeld, C., Krieglstein, G.K. Invest. Ophthalmol. Vis. Sci. (2001)
- Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma. Quaranta, L., Gandolfo, F., Turano, R., Rovida, F., Pizzolante, T., Musig, A., Gandolfo, E. Invest. Ophthalmol. Vis. Sci. (2006)
- Acute effects of PGF2alpha on MMP-2 secretion from human ciliary muscle cells: a PKC- and ERK-dependent process. Husain, S., Jafri, F., Crosson, C.E. Invest. Ophthalmol. Vis. Sci. (2005)
- Effect of latanoprost on outflow facility in the mouse. Crowston, J.G., Aihara, M., Lindsey, J.D., Weinreb, R.N. Invest. Ophthalmol. Vis. Sci. (2004)
- Latanoprost stimulates secretion of matrix metalloproteinases in tenon fibroblasts both in vitro and in vivo. Mietz, H., Esser, J.M., Welsandt, G., Kociok, N., Hueber, A., Joussen, A., Esser, P., Krieglstein, G.K. Invest. Ophthalmol. Vis. Sci. (2003)
- Effects of topical latanoprost on optic nerve head circulation in rabbits, monkeys, and humans. Ishii, K., Tomidokoro, A., Nagahara, M., Tamaki, Y., Kanno, M., Fukaya, Y., Araie, M. Invest. Ophthalmol. Vis. Sci. (2001)
- Prostaglandin FP agonists alter metalloproteinase gene expression in sclera. Weinreb, R.N., Lindsey, J.D., Marchenko, G., Marchenko, N., Angert, M., Strongin, A. Invest. Ophthalmol. Vis. Sci. (2004)
- Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide. Richter, M., Krauss, A.H., Woodward, D.F., Lütjen-Drecoll, E. Invest. Ophthalmol. Vis. Sci. (2003)
- Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation. Ota, T., Murata, H., Sugimoto, E., Aihara, M., Araie, M. Invest. Ophthalmol. Vis. Sci. (2005)
- Effect of latanoprost on intraocular pressure in mice lacking the prostaglandin FP receptor. Crowston, J.G., Lindsey, J.D., Aihara, M., Weinreb, R.N. Invest. Ophthalmol. Vis. Sci. (2004)
- Latanoprost induces matrix metalloproteinase-1 expression in human nonpigmented ciliary epithelial cells through a cyclooxygenase-2-dependent mechanism. Hinz, B., Rösch, S., Ramer, R., Tamm, E.R., Brune, K. FASEB J. (2005)
- Enhancement of scleral macromolecular permeability with prostaglandins. Weinreb, R.N. Transactions of the American Ophthalmological Society. (2001)
- Prostaglandin derivates as ocular hypotensive agents. Alm, A. Progress in retinal and eye research. (1998)